Literature DB >> 28449525

Recalcitrant small cell lung cancer: the argument for optimism.

Karen G Zeman1, Christina E Brzezniak1, Corey A Carter1.   

Abstract

Entities:  

Year:  2017        PMID: 28449525      PMCID: PMC5394078          DOI: 10.21037/jtd.2017.03.40

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  7 in total

Review 1.  Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?

Authors:  Paul A Bunn; John D Minna; Alexander Augustyn; Adi F Gazdar; Youcef Ouadah; Mark A Krasnow; Anton Berns; Elisabeth Brambilla; Natasha Rekhtman; Pierre P Massion; Matthew Niederst; Martin Peifer; Jun Yokota; Ramaswamy Govindan; John T Poirier; Lauren A Byers; Murry W Wynes; David G McFadden; David MacPherson; Christine L Hann; Anna F Farago; Caroline Dive; Beverly A Teicher; Craig D Peacock; Jane E Johnson; Melanie H Cobb; Hans-Guido Wendel; David Spigel; Julien Sage; Ping Yang; M Catherine Pietanza; Lee M Krug; John Heymach; Peter Ujhazy; Caicun Zhou; Koichi Goto; Afshin Dowlati; Camilla Laulund Christensen; Keunchil Park; Lawrence H Einhorn; Martin J Edelman; Giuseppe Giaccone; David E Gerber; Ravi Salgia; Taofeek Owonikoko; Shakun Malik; Niki Karachaliou; David R Gandara; Ben J Slotman; Fiona Blackhall; Glenwood Goss; Roman Thomas; Charles M Rudin; Fred R Hirsch
Journal:  J Thorac Oncol       Date:  2016-01-30       Impact factor: 15.609

2.  Expression of p16 and lack of pRB in primary small cell lung cancer.

Authors:  J Yuan; J Knorr; M Altmannsberger; G Goeckenjan; A Ahr; A Scharl; K Strebhardt
Journal:  J Pathol       Date:  1999-11       Impact factor: 7.996

Review 3.  Clinical Implications of Genomic Discoveries in Lung Cancer.

Authors:  Charles Swanton; Ramaswamy Govindan
Journal:  N Engl J Med       Date:  2016-05-12       Impact factor: 91.245

4.  Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study.

Authors:  Charles M Rudin; M Catherine Pietanza; Todd M Bauer; Neal Ready; Daniel Morgensztern; Bonnie S Glisson; Lauren A Byers; Melissa L Johnson; Howard A Burris; Francisco Robert; Tae H Han; Sheila Bheddah; Noah Theiss; Sky Watson; Deepan Mathur; Bharathi Vennapusa; Hany Zayed; Satwant Lally; Donald K Strickland; Ramaswamy Govindan; Scott J Dylla; Stanford L Peng; David R Spigel
Journal:  Lancet Oncol       Date:  2016-12-05       Impact factor: 41.316

5.  High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumors.

Authors:  D D'Amico; D Carbone; T Mitsudomi; M Nau; J Fedorko; E Russell; B Johnson; D Buchhagen; S Bodner; R Phelps
Journal:  Oncogene       Date:  1992-02       Impact factor: 9.867

6.  A small-cell lung cancer genome with complex signatures of tobacco exposure.

Authors:  Erin D Pleasance; Philip J Stephens; Sarah O'Meara; David J McBride; Alison Meynert; David Jones; Meng-Lay Lin; David Beare; King Wai Lau; Chris Greenman; Ignacio Varela; Serena Nik-Zainal; Helen R Davies; Gonzalo R Ordoñez; Laura J Mudie; Calli Latimer; Sarah Edkins; Lucy Stebbings; Lina Chen; Mingming Jia; Catherine Leroy; John Marshall; Andrew Menzies; Adam Butler; Jon W Teague; Jonathon Mangion; Yongming A Sun; Stephen F McLaughlin; Heather E Peckham; Eric F Tsung; Gina L Costa; Clarence C Lee; John D Minna; Adi Gazdar; Ewan Birney; Michael D Rhodes; Kevin J McKernan; Michael R Stratton; P Andrew Futreal; Peter J Campbell
Journal:  Nature       Date:  2009-12-16       Impact factor: 49.962

7.  Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients.

Authors:  Ekaterina A Semenova; Min-Chul Kwon; Kim Monkhorst; Ji-Ying Song; Rajith Bhaskaran; Oscar Krijgsman; Thomas Kuilman; Dennis Peters; Wieneke A Buikhuisen; Egbert F Smit; Colin Pritchard; Miranda Cozijnsen; Jan van der Vliet; John Zevenhoven; Jan-Paul Lambooij; Natalie Proost; Erwin van Montfort; Arno Velds; Ivo J Huijbers; Anton Berns
Journal:  Cell Rep       Date:  2016-06-30       Impact factor: 9.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.